But the administrator of the Centers for Medicare & Medicaid Services (CMS), Mehmet Oz, MD, said in a post on the social ...

SAN FRANCISCO -- Two studies demonstrated the benefits of treating juvenile myasthenia gravis (MG) with newer drugs.

The resulting 124 I-evuzamitide (previously known as AT-01) has been shown to detect amyloidosis in organs like the heart, ...

Data from the 52-week follow-up of the phase III MINT trial of inebilizumab (Uplizna) in generalized myasthenia gravis was presented at the American Association of Neuromuscular & Electrodiagnostic ...

While hospitals, schools, and churches were previously considered "off limits" for Immigration and Customs Enforcement (ICE) arrests, nurses are increasingly finding themselves in the middle of ...

Maine Family Planning fought the halting of Medicaid dollars in federal court, but it suffered a setback in August when a ...

The trial tested two doses of claseprubart -- 300 mg and 600 mg -- and its primary endpoint was safety. Secondary outcomes ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

Johansson and team also found that longer use of hormonal contraceptives resulted in an increased breast cancer risk. Use of ...

PHOENIX -- An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in ...

Sen. Bill Cassidy, MD (R-La.), chair of the committee, applauded medical innovations of the last few decades including ...